Bei Chen

Principal Research Scientist at Centocor - , N/A, US

Bei Chen's Colleagues at Centocor
Steven Petrosino

Principal Clinical Scientist

Contact Steven Petrosino

Merle Elloso

Principal Research Scientist

Contact Merle Elloso

Chistine Ward

Principal Research Scientist

Contact Chistine Ward

Manjula Reddy

principal research scientist

Contact Manjula Reddy

GANANATH ROUT

PROFESSOR IN MATHEMATICS

Contact GANANATH ROUT

View All Bei Chen's Colleagues
Bei Chen's Contact Details
HQ
610-651-6000
Location
Company
Centocor
Bei Chen's Company Details
Centocor logo, Centocor contact details

Centocor

, N/A, US • 1000 - 4999 Employees
BioTech/Drugs

Subsidiary of Johnson & Johnson, Centocor is a biotechnology company that was founded in Philadelphia in 1979 with an initial goal of developing new diagnostic assays using monoclonal antibody technology.In 1982 Centocor developed their first product approved by the U.S. Food and Drug Administration (FDA) — a diagnostic test used to detect the rabies virus, and in that same year transitioned into a publicly traded company. Subsequently, the company moved to a larger facility in Malvern, Pennsylvania (a northwest suburb of Philadelphia). In 1984, Centocor opened an overseas plant in Leiden, the Netherlands.Eighteen years after its foundation, (in 1997), Centocor achieved its first year of operating profitability. In 1998, Centocor divested itself of its diagnostic division and launched its top-selling monoclonal antibody Remicade (infliximab) for its first FDA approved indication in Crohn's Disease. In 1999, Centocor became a wholly owned subsidiary of Johnson & Johnson, the worldwide manufacturer and marketer of healthcare products. Subsequently, Remicade's market has expanded with approvals for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, and pediatric Crohn's disease. Remicade was approved for plaque psoriasis in September 2006.Centocor also markets ReoPro (abciximab), a biologic agent indicated as an adjunct to coronary angioplasty (PTCA).Since being acquired by Johnson and Johnson, Centocor has increased its annual sales from approximately $500 million to more than $2 billion. During the same period, research and development investment increased from $75 million to more than $300 million.In 2004 Centocor purchased a new manufacturing plant in St. Louis, Missouri, and is currently opening a new manufacturing facility in County Cork, Ireland. The Dutch plant has been expanded substantially with a $250 million investment in additional production facilities, which were opened in 2006.

BioTech/Drugs Commercial Physical Research Biotechnology
Details about Centocor
Frequently Asked Questions about Bei Chen
Bei Chen currently works for Centocor.
Bei Chen's role at Centocor is Principal Research Scientist.
Bei Chen's email address is ***@centocor.com. To view Bei Chen's full email address, please signup to ConnectPlex.
Bei Chen works in the Biotechnology industry.
Bei Chen's colleagues at Centocor are Steven Petrosino, Brett Ware, Merle Elloso, Gary Toedter, Chistine Ward, Manjula Reddy, GANANATH ROUT and others.
Bei Chen's phone number is ["+12153252507"]
See more information about Bei Chen